HGSI 13.62 -0.01 / Human Genome Sciences, Inc. HGSI 13.62 -0.01 / Human Genome Sciences, Inc. Price Target | Benzinga

Wednesday, April 25, 2012

UPDATE: J.P. Morgan Maintains Overweight Rating, Raises PT for Human Genome Sciences (Analyst Color, HGSI, Price Target, Reiteration, Analyst Ratings / Wed, 09:30am)

Friday, April 20, 2012

Amarin Soars on JP Morgan Initiation (AMRN, Analyst Color, GSK, HGSI, Price Target, Initiation, Intraday Update, Analyst Ratings, Movers / Fri, 03:25pm)

Tuesday, February 28, 2012

Brean Murray Carret Maintains Hold on Human Genome Sciences (Analyst Color, HGSI, Price Target, Reiteration, Intraday Update, Analyst Ratings / Tue, 11:24am)

Thursday, February 23, 2012

UPDATE: Collins Stewart Downgrades Human Genome Sciences to Neutral (Analyst Color, HGSI, Downgrades, Price Target, Pre-Market Outlook, Analyst Ratings / Thu, 10:28am)

Wednesday, December 21, 2011

Citigroup Lowers PT on Human Genome Sciences to $8 (HGSI, Price Target, Analyst Ratings / Wed, 11:05am)

Wednesday, October 26, 2011

Brean Murray Downgrades Human Genome Sciences to Hold, Removes PT (HGSI, Downgrades, Price Target, Analyst Ratings / Wed, 08:50am)
UPDATE: Piper Jaffray Lowers PT to $15 on Human Genome Sciences (Analyst Color, Earnings, HGSI, News, Price Target, Analyst Ratings / Wed, 08:33am)
Piper Jaffray Lowers PT on Human Genome Sciences to $15 (HGSI, Price Target, Analyst Ratings / Wed, 06:18am)

Friday, September 02, 2011

UPDATE: Bank of America Merrill Lynch Lowers PO on Human Genome Sciences to $13 (Analyst Color, HGSI, Price Target, Analyst Ratings / Fri, 08:20am)
Bank of America Lowers PO On Human Genome Sciences To $13 (HGSI, Price Target, Analyst Ratings / Fri, 05:43am)

Wednesday, August 31, 2011

UPDATE: Citi Lowers Price Target On Human Genome Sciences To $15 (Analyst Color, HGSI, Price Target, Analyst Ratings / Wed, 08:58am)
Citigroup Lowers PT On Human Genome Sciences To $15 (HGSI, Price Target, Analyst Ratings / Wed, 06:06am)

Tuesday, August 23, 2011

Brean Murray Initiates Human Genome Sciences At Buy, $22 PT (HGSI, Price Target, Initiation, Analyst Ratings / Tue, 06:26am)

Monday, August 08, 2011

Citadel Initiates Human Genome Sciences With Add Rating, $25 PT (HGSI, Price Target, Initiation, Analyst Ratings / Mon, 06:02am)

Friday, July 22, 2011

UPDATE: Piper Jaffray Lowering Price Target On Human Genome Sciences (Analyst Color, HGSI, Price Target, Analyst Ratings / Fri, 08:01am)
Piper Jaffray Lowers PT On Human Genome Sciences To $31 (HGSI, Price Target, Analyst Ratings / Fri, 06:08am)

Friday, April 15, 2011

J.P. Morgan Reiterates Overweight Rating on Human Genome Sciences (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Fri, 09:18am)
Piper Jaffray Raises PT On Human Genome Sciences To $36 (HGSI, Price Target, Analyst Ratings / Fri, 07:12am)

Thursday, March 10, 2011

Goldman Sachs Raises HGSI Target From $25 To $28 (HGSI, Price Target, Analyst Ratings / Thu, 09:37am)

Thursday, January 20, 2011

Piper Jaffray Lowers Price Target On Human Genome Sciences (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Thu, 08:25am)
Piper Jaffray Lowers PT On Human Genome Sciences (HGSI, Price Target, Analyst Ratings / Thu, 07:45am)

Tuesday, January 11, 2011

Citi Has High Risk Rating On Human Genome Sciences (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Tue, 08:58am)

Monday, December 06, 2010

FDA Delays PDUFA on HGSI's Benlysta (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Mon, 09:28am)
J.P. Morgan Overweight On Human Genome Sciences (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Mon, 08:38am)

Wednesday, November 10, 2010

J.P. Morgan Reiterates Overweight Rating on Human Genome (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Wed, 10:27am)

Tuesday, November 09, 2010

Piper Jaffray Overweight On Human Genome Sciences (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Tue, 08:12am)

Thursday, November 04, 2010

RBC Positive On Human Genome Sciences (HGSI) (Analyst Color, HGSI, Price Target, Analyst Ratings / Thu, 04:09pm)
J.P. Morgan Discusses Dendreon & Human Genome Sciences (DNDN, HGSI) (Analyst Color, DNDN, HGSI, Price Target, Analyst Ratings / Thu, 03:00pm)

Monday, October 11, 2010

HGSI Removed From Citigroup's Top Picks Live! List (Analyst Color, HGSI, Downgrades, Price Target, Analyst Ratings / Mon, 06:58am)

Monday, December 21, 2009

Benlysta Approval Could Lift Human Genome Sciences (HGSI) (HGSI, Price Target, Initiation, Analyst Ratings / Mon, 02:52pm)

Tuesday, November 03, 2009

JPMorgan Ups Target On Human Genome Sciences (HGSI) To $35 (HGSI, Price Target, Analyst Ratings / Tue, 08:51am)

Monday, November 02, 2009

Human Genome Sciences Up 22% In The Pre-Market (GSK, HGSI, News, Price Target, FDA, Pre-Market Outlook, Analyst Ratings, Movers / Mon, 07:54am)